The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis
Pathologic complete response of DCIS to NACT occurred in 53.6 % of TNBC patients. Future studies are required to be able to predict DCIS response based on clinicopathological variables and imaging.
Authors
- Thiemo J. A. van Nijnatten (ORCID: https://orcid.org/0000-0002-6431-3538)
- Marjolein Louisa Smidt (ORCID: https://orcid.org/0000-0002-8328-1869)
- Roxanne A W Ploumen (ORCID: https://orcid.org/0000-0003-1024-3519)
- Loes F. S. Kooreman (ORCID: https://orcid.org/0000-0001-8226-8665)
- Sabine Siesling (ORCID: https://orcid.org/0000-0002-0273-824X)
- Maartje A.C.E. van Kats
- Eva L Claassens
Institutions
- Maastricht University Medical Centre (NL)
Publication Details
- Journal
- The Breast
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1016/j.breast.2025.104425
- Citations
- 2
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.87